Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dag Nyholm

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Parkinsonism & Related Disorders|August 21, 2007
The rationale for continuous dopaminergic stimulation in advanced Parkinson's diseaseDag Nyholm
Expert Review of Neurotherapeutics|November 3, 2006
Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's diseaseDag Nyholm
Parkinsonism & Related Disorders|July 25, 2012
Duodopa® treatment for advanced Parkinson's disease: a review of efficacy and safetyDag Nyholm
Clinical Pharmacokinetics|February 21, 2006
Pharmacokinetic optimisation in the treatment of Parkinson's disease : an updateDag Nyholm
CNS Drugs|December 11, 2013
Continuous drug delivery in Parkinson's diseaseMarina Senek, Dag Nyholm
Journal of Parkinson'S Disease|January 9, 2014
Levodopa fractionation in Parkinson's diseaseDag Nyholm, Victoria Stepien
Movement Disorders Clinical Practice|October 24, 2024
A 4-Year Follow-Up of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Parkinson's DiseaseMezin Öthman, Dag Nyholm
Journal of Personalized Medicine|February 25, 2022
Optimizing Treatment of Parkinson's DiseaseDag Nyholm, Filip Bergquist
Therapeutic Advances in Neurological Disorders|March 28, 2017
Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experienceJohan Virhammar, Dag Nyholm
Journal of Neural Transmission (Vienna, Austria : 1996)|September 2, 2025
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusionPeter Jenner, Dag Nyholm
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Parkinsonism & Related Disorders|August 21, 2007
The rationale for continuous dopaminergic stimulation in advanced Parkinson's diseaseDag Nyholm
Expert Review of Neurotherapeutics|November 3, 2006
Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's diseaseDag Nyholm
Parkinsonism & Related Disorders|July 25, 2012
Duodopa® treatment for advanced Parkinson's disease: a review of efficacy and safetyDag Nyholm
Clinical Pharmacokinetics|February 21, 2006
Pharmacokinetic optimisation in the treatment of Parkinson's disease : an updateDag Nyholm
CNS Drugs|December 11, 2013
Continuous drug delivery in Parkinson's diseaseMarina Senek, Dag Nyholm
Journal of Parkinson'S Disease|January 9, 2014
Levodopa fractionation in Parkinson's diseaseDag Nyholm, Victoria Stepien
Movement Disorders Clinical Practice|October 24, 2024
A 4-Year Follow-Up of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Parkinson's DiseaseMezin Öthman, Dag Nyholm
Journal of Personalized Medicine|February 25, 2022
Optimizing Treatment of Parkinson's DiseaseDag Nyholm, Filip Bergquist
Therapeutic Advances in Neurological Disorders|March 28, 2017
Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experienceJohan Virhammar, Dag Nyholm
Journal of Neural Transmission (Vienna, Austria : 1996)|September 2, 2025
COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusionPeter Jenner, Dag Nyholm
Pageof 11